Benzinga | Nov 10, 2021 05:01PM EST

4D Molecular Therapeutics Q3 EPS $(0.82) Up From $(1.51) YoY, Sales $1.37M Down From $7.42M YoY

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.82) per share. This is a 45.7 percent increase over losses of $(1.51) per share from the same period last year. The company reported $1.37 million in sales this quarter. This is a 81.59 percent decrease over sales of $7.42 million the same period last year.